A pharmaceutically active agent, a pharmaceutically active agent carrier
and method of use thereof are described. In some embodiments, a system
may include a composition. The composition may include one or more
bridged polycyclic compounds. At least one of the bridged polycyclic
compounds may include at least two cyclic groups, and at least two
pharmaceutically active agents may be associated with the bridged
polycyclic compound. In some embodiments, one or more bridged polycyclic
compounds may be administered to a subject to improve cardiac and/or
cardiovascular health. In some embodiments, one or more bridged
polycyclic compounds may be administered to a subject to control
cholesterol levels.